Kobayashi Pharmaceutical
Kobayashi Pharmaceutical Co Ltd is a Japanese multinational over-the-counter (OTC) pharmaceuticals, health care products, toiletries, and household goods manufacturing enterprise specializing in the research, development, production, and global wholesale distribution of innovative consumer healthcare remedies, sanitary products, aromatic deodorizers, and specialized personal care items distributed across Japan, the United States, China, and international markets. Operating advanced manufacturing complexes and R&D laboratories in Japan, the company is renowned for creating niche consumer products addressing everyday health and lifestyle needs. Its core business operations encompass OTC pharmaceutical manufacturing, consumer health product development, household goods production, and international wholesale distribution. Revenue is derived directly from the wholesale sale of over-the-counter drugs, health supplements, and household sanitary products to retail pharmacies, drugstores, and supermarket chains. Kobayashi Pharmaceutical holds a leading market position in niche OTC healthcare products and household sanitary goods in Japan. The company is headquartered in Osaka, Japan, and its shares trade on the Tokyo Stock Exchange (TSE Prime Market).
3 of the funds FundTelligence covers report a position in Kobayashi Pharmaceutical.
- Legal name
- Kobayashi Pharmaceutical Co Ltd
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 3
Funds holding Kobayashi Pharmaceutical
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.03 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)